North Attleboro, MA, United States of America

Michael Reardon

USPTO Granted Patents = 15 (Patent Applications = 2)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 47(Granted Patents)

Company Filing History:

Years Active: 2014-2025

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12252504 - Oligosaccharide-protein conjugates (2025-03-18),

2. 11981688 - Methods of preparing cytotoxic benzodiazepine derivatives (2024-05-14),

3. 11591296 - Methods of preparing cytotoxic benzodiazepine derivatives (2023-02-28),

4. 11396519 - Methods of preparing cytotoxic benzodiazepine derivatives (2022-07-26),

5. 11279725 - Oligosaccharide-protein conjugates (2022-03-22),

6. 11274121 - Methods for antibody drug conjugation, purification, and formulation (2022-03-15),

7. 10954230 - Method of preparing glucosylceramide synthase inhibitors (2021-03-23),

8. 10913713 - Methods of preparing cytotoxic benzodiazepine derivatives (2021-02-09),

9. 10851117 - Methods of preparing cytotoxic benzodiazepine derivatives (2020-12-01),

10. 10604518 - Method of preparing glucosylceramide synthase inhibitors (2020-03-31),

11. 10464962 - Oligosaccharide-protein conjugates (2019-11-05),

12. 10065949 - Method of preparing glucosylceramide synthase inhibitors (2018-09-04),

13. 9682975 - Method of preparing glucosylceramide synthase inhibitors (2017-06-20),

14. 9493498 - Oligosaccharide-protein conjugates (2016-11-15),

15. 8835614 - Oligosaccharide-protein conjugates (2014-09-16),

Title: Michael Reardon: Innovator in Biopharmaceuticals

Introduction

Michael Reardon is a distinguished inventor based in North Attleboro, MA, with a remarkable portfolio of 15 patents. His work primarily focuses on biopharmaceutical innovations, contributing significantly to the field of medicine.

Latest Patents

Among his latest patents, Reardon has developed oligosaccharide-protein conjugates. These conjugates comprise a protein and an oligosaccharide of specific formulae, which are crucial for creating pharmaceutical compositions. Additionally, he has devised methods for treating lysosomal storage disorders in mammals through the administration of oligosaccharide-glycoprotein conjugates. Another notable patent involves novel methods for preparing cytotoxic benzodiazepine derivatives, specifically indolinobenzodiazepine dimer compounds and their synthetic precursors.

Career Highlights

Reardon has had a significant impact on the biopharmaceutical industry through his work with prominent companies such as Genzyme Corporation and Immunogen, Inc. His contributions have advanced the development of innovative treatments and therapies.

Collaborations

Throughout his career, Reardon has collaborated with notable professionals, including Richard A. Silva and Luis Z. Avila. These partnerships have fostered a collaborative environment that enhances innovation and research.

Conclusion

Michael Reardon stands out as a key figure in the field of biopharmaceuticals, with a strong record of patents and collaborations that highlight his innovative spirit. His work continues to influence the development of new medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.